The Doctors Company acquires ProAssurance
Analysis based on 6 articles · First reported Jun 26, 2026 · Last updated Jun 29, 2026
The acquisition of ProAssurance by The Doctors Company creates a larger entity in the medical professional liability insurance market, potentially leading to increased competition and consolidation within the insurance industry. This could affect other insurance providers and healthcare organizations seeking coverage. The delisting of ProAssurance's stock from the New York Stock Exchange also impacts its former shareholders.
The Doctors Company, the largest physician-owned medical malpractice insurer, has completed its acquisition of ProAssurance Corporation, a specialty insurer, for approximately $1.3 billion. The transaction, valued at $25.00 per share in cash, was approved by ProAssurance shareholders in June 2025. As a result, ProAssurance's common stock has been deregistered with the United States — United States Securities and Exchange Commission and delisted from the New York Stock Exchange, ceasing public trading. ProAssurance will now operate as a wholly owned subsidiary of The Doctors Company. This merger significantly expands the combined company's assets to $12 billion and its reach to over 200,000 healthcare professionals and organizations, making The Doctors Company the second-largest provider of medical professional liability insurance in the United States, behind Berkshire Hathaway's MedPro Group. Richard Johan Anderson continues as Chairman and CEO of The Doctors Company and SK Group, while Edward Kennard Rand remains President and CEO of ProAssurance during the integration.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard